Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.54 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.54 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | CRHBP | P24387 | 1/20 | 0.46 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | CASP1 | P29466 | 1/20 | 0.45 |
| ▸ | CASP7 | P55210 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 3/20 | 0.42 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.42 |
| ▸ | APP | P05067 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1234308 | 0.97 | ALDH1A1 (0.52) | ALDH1A1TDP1ADRA2BPTGS1MAPT | |
| SCHEMBL365525 | 0.80 | ALDH1A1 (0.50) | ALDH1A1TDP1ADRA2BPTGS1MAPT | |
| SCHEMBL81185 | 0.75 | KDM4E (0.65) | ALDH1A1TDP1ADRA2BPTGS1MAPT | |
| SCHEMBL29508342 | 0.75 | KDM4E (0.65) | ALDH1A1TDP1ADRA2BPTGS1MAPT | |
| SCHEMBL863708 | 0.75 | ALDH1A1 (0.62) | ALDH1A1TDP1ADRA2BPTGS1MAPT | |
| SCHEMBL30979203 | 0.75 | KDM4E (0.65) | ALDH1A1TDP1ADRA2BPTGS1MAPT | |
| Biphenyl SCHEMBL2308329 | 0.73 | ALDH1A1 (0.44) | ALDH1A1TDP1ADRA2BPTGS1MAPT | |
| SCHEMBL6289306 | 0.72 | KDM4E (0.62) | ALDH1A1TDP1ADRA2BPTGS1MAPT | |
| SCHEMBL1361220 | 0.72 | KDM4E (0.62) | ALDH1A1TDP1ADRA2BPTGS1MAPT | |
| Hydrochloric Acid SCHEMBL11737056 | 0.72 | KDM4E (0.62) | ALDH1A1TDP1ADRA2BPTGS1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 307 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12379383-B2 | Proteoform specific process validation | Novilytic, LLC (US) | 2025-08-05 | — | — | US | claimed |
| EP-4204158-A1 | PROTEOFORM SPECIFIC PROCESS VALIDATION | Novilytic, LLC (US) | 2023-07-05 | — | — | EP | claimed |
| US-20220137063-A1 | Proteoform Specific Process Validation | TENAX BIOANALYTICS, LLC | 2022-05-05 | — | — | US | claimed |
| WO-2022060947-A1 | PROTEOFORM SPECIFIC PROCESS VALIDATION | Novilytic, LLC (US) | 2022-03-24 | — | — | WO | claimed |
| US-10995104-B2 | Catalysts for reversing formaldehyde adducts and crosslinks | ROCHE MOLECULAR SYSTEM, INC. (US) | 2021-05-04 | — | — | US | claimed |
| EP-3634470-A1 | GLUCOSE SENSITIVE COMPOSITIONS FOR DRUG DELIVERY | North Carolina State University (US) | 2020-04-15 | — | — | EP | claimed |
| EP-3631408-A1 | CATALYSTS FOR REVERSING FORMALDEHYDE ADDUCTS AND CROSSLINKS | Roche Diagnostics GmbH (DE) | 2020-04-08 | — | — | EP | claimed |
| US-20180370992-A1 | Catalysts for reversing formaldehyde adducts and crosslinks | ROCHE MOLECULAR SYSTEMS, INC. | 2018-12-27 | — | — | US | claimed |
| WO-2018219997-A1 | CATALYSTS FOR REVERSING FORMALDEHYDE ADDUCTS AND CROSSLINKS | ROCHE DIAGNOSTICS GMBH (DE) | 2018-12-06 | — | — | WO | claimed |
| WO-2018223114-A1 | GLUCOSE SENSITIVE COMPOSITIONS FOR DRUG DELIVERY | NORTH CAROLINA STATE UNIVERSITY (US) | 2018-12-06 | — | — | WO | claimed |
| US-8557304-B2 | Method of obtaining secondary plant constituents | SARTORIUS STEDIM BIOTECH GMBH (DE) | 2013-10-15 | — | — | US | claimed |
| US-20120077994-A1 | METHOD OF OBTAINING SECONDARY PLANT CONSTITUENTS | SARTORIUS STEDIM BIOTECH GMBH (DE) | 2012-03-29 | — | — | US | claimed |
| EP-2268805-A1 | LARGE-SCALE PRODUCTION OF SOLUBLE HYALURONIDASE | Halozyme, Inc. (US) | 2011-01-05 | — | — | EP | claimed |
| WO-2009111066-A1 | LARGE-SCALE PRODUCTION OF SOLUBLE HYALURONIDASE | HALOZYME, INC. (US) | 2009-09-11 | — | — | WO | claimed |
| US-20070141678-A1 | Processes for purifying oligosaccharides | THE PROCTER & GAMBLE COMPANY | 2007-06-21 | — | — | US | claimed |
| EP-4746986-A1 | RADIAL FLOW SEPARATION DEVICE | Astrea UK Services Limited (GB) | 2026-05-27 | — | — | EP | disclosed |
| US-12600959-B2 | PH20 polypeptide variants, formulations and uses thereof | HALOZYME, INC. (US) | 2026-04-14 | — | — | US | disclosed |
| EP-0487621-A4 | IMMUNOASSAY OF GLYCOSYLATED PROTEINS EMPLOYING ANTIBODY DIRECTED TO REDUCTIVELY GLYCOSYLATED N-TERMINAL AMINO ACIDS | — | 1992-06-24 | — | — | EP | disclosed |
| EP-0487621-A1 | IMMUNOASSAY OF GLYCOSYLATED PROTEINS EMPLOYING ANTIBODY DIRECTED TO REDUCTIVELY GLYCOSYLATED N-TERMINAL AMINO ACIDS. | UNIV NORTHWESTERN (US) | 1992-06-03 | — | — | EP | disclosed |
| WO-1991002978-A1 | IMMUNOASSAY OF GLYCOSYLATED PROTEINS EMPLOYING ANTIBODY DIRECTED TO REDUCTIVELY GLYCOSYLATED N-TERMINAL AMINO ACIDS | NORTHWESTERN UNIVERSITY (US) | 1991-03-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12600959-B2 | PH20 polypeptide variants, formulations and uses thereof | PREP, HM13, MMP20 | ALDH1A1 1859/4885TDP1 843/4885ADRA2B 4073/4885 |
| US-20180370992-A1 | Catalysts for reversing formaldehyde adducts and crosslinks | FBL, PCNA, UNG | ALDH1A1 724/4885TDP1 395/4885ADRA2B 4249/4885 |
| US-10995104-B2 | Catalysts for reversing formaldehyde adducts and crosslinks | FBL, PCNA, UNG | ALDH1A1 724/4885TDP1 395/4885ADRA2B 4249/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.